TXG · 10x Genomics, Inc. · Share Buybacks
$58.19
-0.91 (-1.54%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.65B
Shares
131.53M
Volume · Nov 13
2.13M
Avg daily vol (3M)
3.35M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2017-12-31 | $80,000 | 10-K, filed 2020-02-27 |
Key facts
CIK
1770787
CUSIP
88025U109
13F (30d)
378 filings
343 filers
Visit website
Investor relations